Molecular Partners AG
MOLN
$3.88
-$0.07-1.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 15.39% | -1.60% | |||
| Gross Profit | -15.39% | 1.60% | |||
| SG&A Expenses | -10.81% | 24.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.12% | 6.31% | |||
| Operating Income | -6.12% | -6.31% | |||
| Income Before Tax | -3.93% | -6.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.90% | -7.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.90% | -7.01% | |||
| EBIT | -6.12% | -6.31% | |||
| EBITDA | -4.01% | -9.25% | |||
| EPS Basic | -3.64% | -6.98% | |||
| Normalized Basic EPS | -3.35% | -8.37% | |||
| EPS Diluted | -3.64% | -6.98% | |||
| Normalized Diluted EPS | -3.35% | -8.37% | |||
| Average Basic Shares Outstanding | 0.24% | 0.04% | |||
| Average Diluted Shares Outstanding | 0.24% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||